Showing 31,841 - 31,860 results of 104,490 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.92s Refine Results
  1. 31841
  2. 31842
  3. 31843

    <b>Phosphate effects on the transformation of Sb(V)-</b><b>bearing </b><b>ferrihydrite under microbial iron- and sulfate-reducing conditions</b> by Man Jae Kwon (21789485)

    Published 2025
    “…Anoxic reactors that contained Sb(V)-bearing ferrihydrite (Fh), varying PO<sub>4</sub><sup>3-</sup> concentrations (0, 0.2, and 2 mM), and sulfate, were inoculated with a microbial community sourced from Sb-contaminated soil. …”
  4. 31844
  5. 31845

    Axial length changes after one week of wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

    Published 2025
    “…A vast majority of cases (82.5%) featured a decrease in axial length after wearing orthokeratology lenses.…”
  6. 31846
  7. 31847
  8. 31848
  9. 31849
  10. 31850

    S1 Dataset - by Gui-Hong Zhang (9284601)

    Published 2023
    “…Tβ4 alleviated oxidative damage by reducing MDA, LDH and ROS and increasing SOD and GSH-PX in Aβ-treated SH-SY5Y cells. We found that Tβ4 inhibit ERK/p38 MAPK pathway and intensify the expression of 5-HTR1A. …”
  11. 31851

    Torque response of DNA loaded with (H3.3-H4)<sub>2</sub> tetrasomes. by Rifka Vlijm (133750)

    Published 2015
    “…(B) The torque stored in DNA loaded with 5 tetrasomes plotted as a function of the number of applied rotations, <i>θ</i>. …”
  12. 31852

    PCR Primers. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  13. 31853

    Suggested model. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  14. 31854

    Mouse antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  15. 31855

    Human antibodies. by Laura Bellassen (22209109)

    Published 2025
    “…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
  16. 31856
  17. 31857

    Inhibition of <i>Tityus serrulatus</i> venom hyaluronidase affects venom biodistribution by Bárbara Bruna Ribeiro de Oliveira-Mendes (6551183)

    Published 2019
    “…A higher concentration of immunoneutralized <sup>99m</sup>Tc-TsV was observed in the kidneys in comparison with the non-treated venom. …”
  18. 31858

    Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan by Shinichi Matsuda (733301)

    Published 2015
    “…The High frequency:Low frequency ratio for peginterferon alpha-2a and sevelamer hydrochloride decreased steadily throughout the study period.…”
  19. 31859
  20. 31860